FOXA1 and nasopharyngeal carcinoma: Additionally, FOXA1 enhances antitumor immunity and reduces immune evasion in NPC by interacting with STAT1 to inhibit IRF1 transcription, thereby suppressing IFN-γ-induced PD-L1 expression [43].